Latest Insider Transactions at Ocular Therapeutix, Inc (OCUL)
This section provides a real-time view of insider transactions for Ocular Therapeutix, Inc (OCUL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OCULAR THERAPEUTIX, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OCULAR THERAPEUTIX, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2023
|
Philip C. Strassburger General Counsel |
SELL
Open market or private sale
|
Direct |
6,181
-5.36%
|
$24,724
$4.24 P/Share
|
|
Feb 06
2023
|
Donald Notman Officer |
SELL
Open market or private sale
|
Direct |
6,476
-4.44%
|
$25,904
$4.24 P/Share
|
|
Feb 06
2023
|
Rabia Gurses Ozden Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,416
-5.95%
|
$25,664
$4.24 P/Share
|
|
Jan 30
2023
|
Philip C. Strassburger General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+32.53%
|
-
|
|
Jan 30
2023
|
Christopher G White Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+30.64%
|
-
|
|
Jan 30
2023
|
Antony C. Mattessich President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
176,300
+27.45%
|
-
|
|
Jan 30
2023
|
Donald Notman Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+27.58%
|
-
|
|
Jan 30
2023
|
Rabia Gurses Ozden Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+34.01%
|
-
|
|
Nov 07
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
7,328
+0.12%
|
$21,984
$3.5 P/Share
|
|
Oct 11
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.16%
|
$30,000
$3.9 P/Share
|
|
Oct 10
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.16%
|
$40,000
$4.0 P/Share
|
|
Sep 29
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
18,800
+0.31%
|
$75,200
$4.04 P/Share
|
|
Sep 28
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
1,200
+0.02%
|
$4,800
$4.1 P/Share
|
|
Sep 27
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
130,000
+2.1%
|
$520,000
$4.68 P/Share
|
|
Jul 01
2022
|
Rabia Gurses Ozden Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,667
+11.32%
|
-
|
|
Jun 16
2022
|
Jeffrey S. Heier Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+15.71%
|
-
|
|
Jun 16
2022
|
Seung Suh Hong Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+50.0%
|
-
|
|
Jun 16
2022
|
Richard L Md Lindstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+7.61%
|
-
|
|
Jun 16
2022
|
Charles M Warden Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+15.56%
|
-
|
|
Jun 16
2022
|
Leslie J. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+39.94%
|
-
|
|
Jun 16
2022
|
Merilee Raines Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+50.0%
|
-
|
|
May 12
2022
|
Jeffrey S. Heier Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+27.78%
|
$45,000
$3.05 P/Share
|
|
May 12
2022
|
Richard L Md Lindstrom Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,469
+8.69%
|
$9,469
$1.22 P/Share
|
|
Feb 23
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.17%
|
$40,000
$4.8 P/Share
|
|
Feb 18
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.67%
|
$200,000
$5.0 P/Share
|
|
Feb 03
2022
|
Antony C. Mattessich President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
186,750
+39.2%
|
-
|
|
Feb 03
2022
|
Michael H. Goldstein President, Ophthalmology & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
63,333
+16.81%
|
-
|
|
Feb 03
2022
|
Christopher G White Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.96%
|
-
|
|
Feb 03
2022
|
Philip C. Strassburger General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.11%
|
-
|
|
Feb 03
2022
|
Donald Notman Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+40.5%
|
-
|
|
Jan 28
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
4,023
+0.07%
|
$20,115
$5.2 P/Share
|
|
Jan 27
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
1,477
+0.03%
|
$7,385
$5.2 P/Share
|
|
Jan 24
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
44,400
+0.75%
|
$222,000
$5.31 P/Share
|
|
Jan 21
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
12,152
+0.21%
|
$60,760
$5.56 P/Share
|
|
Jan 20
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
17,948
+0.31%
|
$89,740
$5.7 P/Share
|
|
Jan 18
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
6,807
+0.12%
|
$40,842
$6.0 P/Share
|
|
Jan 14
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
33,193
+0.57%
|
$199,158
$6.03 P/Share
|
|
Jan 13
2022
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.17%
|
$60,000
$6.2 P/Share
|
|
Dec 15
2021
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.26%
|
$90,000
$6.22 P/Share
|
|
Dec 14
2021
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
29,490
+0.51%
|
$176,940
$6.41 P/Share
|
|
Dec 13
2021
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
10,510
+0.18%
|
$63,060
$6.5 P/Share
|
|
Dec 10
2021
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.52%
|
$180,000
$6.65 P/Share
|
|
Dec 08
2021
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
5,300
+0.09%
|
$31,800
$6.75 P/Share
|
|
Dec 06
2021
|
Summer Road LLC |
BUY
Open market or private purchase
|
Indirect |
55,600
+0.97%
|
$333,600
$6.13 P/Share
|
|
Aug 20
2021
|
Antony C. Mattessich President and CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+4.63%
|
$45,000
$9.89 P/Share
|
|
May 20
2021
|
Richard L Md Lindstrom Director |
SELL
Open market or private sale
|
Direct |
10,000
-10.0%
|
$140,000
$14.3 P/Share
|
|
Feb 15
2021
|
Charles M Warden Director |
SELL
Other acquisition or disposition
|
Indirect |
1,840,505
-100.0%
|
-
|
|
Feb 15
2021
|
Charles M Warden Director |
BUY
Other acquisition or disposition
|
Direct |
35,912
+47.6%
|
-
|
|
Feb 15
2021
|
Charles M Warden Director |
BUY
Other acquisition or disposition
|
Indirect |
375,121
+50.0%
|
-
|
|
Dec 04
2020
|
Charles M Warden Director |
SELL
Other acquisition or disposition
|
Indirect |
787,208
-55.9%
|
-
|